Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired lipoprotein secretion by APOE4 leads to lysosomal and mitochondrial dysfunction in human microglia.

bioRxiv : the preprint server for biology·2026
Same author

Aberrant CD4<sup>+</sup> T cell refeeding response impairs neuro-immune crosstalk in Parkinson's disease.

bioRxiv : the preprint server for biology·2026
Same author

Scalable longitudinal imaging and transcriptomics of cells in dynamic enclosures.

bioRxiv : the preprint server for biology·2026
Same author

RUNX1 and YY1 modulate neuronal fate and energy metabolism in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

CK2 inhibition suppresses glial inflammation in models of neuroinflammation and neurodegeneration.

Nature communications·2026
Same author

DNA damage drives a unique, Alzheimer's disease-relevant senescent state in neurons.

bioRxiv : the preprint server for biology·2026
Same journal

Psychological stress drives aging-like hematopoietic stem cell dysfunction through a brain-gut-bone marrow axis.

Cell stem cell·2026
Same journal

Human stem cell-based embryo model governance: Insights from Japan.

Cell stem cell·2026
Same journal

From reconstruction to intervention: Engineered organoids as living therapeutic depots.

Cell stem cell·2026
Same journal

Long-term lessons from MATCH01 macrophage therapy in cirrhosis.

Cell stem cell·2026
Same journal

Beyond apoptosis: LSC state dictates metabolic and anti-apoptotic vulnerabilities.

Cell stem cell·2026
Same journal

Outside the niche: Gut microbiota relay psychological stress to hematopoietic stem cell dysfunction.

Cell stem cell·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Fabrication of Amyloid-&#946;-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

Modeling brain disease in a dish: really?

Maria C Marchetto1, Fred H Gage1

  • 1Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.

Cell Stem Cell
|June 19, 2012
PubMed
Summary
This summary is machine-generated.

Cellular programming and reprogramming technology (CPART) offers new ways to study brain diseases. This technology helps develop diagnostic tools and therapies by overcoming modeling challenges.

More Related Videos

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Fabrication of Amyloid-&#946;-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

Area of Science:

  • Neuroscience
  • Biotechnology
  • Medical Research

Background:

  • Cellular programming and reprogramming technology (CPART) is an emerging field with significant potential.
  • Understanding disease mechanisms and progression is crucial for therapeutic development.
  • Modeling complex diseases like those affecting the brain presents unique challenges.

Purpose of the Study:

  • To discuss the obstacles encountered when using CPART for modeling brain diseases.
  • To explore potential solutions and strategies for overcoming these challenges.
  • To highlight the promise of CPART in advancing brain disease research and therapeutics.

Main Methods:

  • The Forum convenes experts to discuss current limitations in CPART application to neurological disorders.
  • Case studies and theoretical frameworks are presented to illustrate challenges.
  • Collaborative problem-solving sessions are employed to identify viable solutions.

Main Results:

  • Key obstacles identified include cell-type specificity, scalability, and integration with existing biological knowledge.
  • Potential solutions involve advancements in gene-editing tools, organoid development, and computational modeling.
  • The discussion highlights the need for standardized protocols and interdisciplinary collaboration.

Conclusions:

  • CPART holds significant promise for understanding brain disease mechanisms and progression.
  • Overcoming current obstacles is essential for realizing CPART's full potential in diagnostics and therapeutics.
  • Continued research and technological innovation are vital for advancing CPART in neuroscience.